Which of the following is NOT a common side effect of hormone therapy?

Which of the following is NOT a common side effect of hormone therapy?

• A. Hair loss
• B. Breast tenderness
• C. Nausea
• D. Headaches

Answer: (B)

The main idea here is recognizing which symptoms are most commonly caused by menopausal hormone therapy. Across standard regimens, headaches, nausea, and changes in hair are frequently reported adverse effects. Breast tenderness, while it can occur with estrogen-containing therapies, is not consistently listed among the most common side effects in many summaries, and its frequency can vary with formulation, dose, and delivery method. Because of that variability, breast tenderness is the one most likely to be described as not a common side effect in this context. Keep in mind that individual experiences can differ: some women may notice breast tenderness more with certain regimens, while others may have little or no tenderness. If tenderness develops, it’s reasonable to reassess the regimen and monitor for other potential causes, but overall the other listed symptoms tend to be more consistently encountered with hormone therapy.

The main idea here is recognizing which symptoms are most commonly caused by menopausal hormone therapy. Across standard regimens, headaches, nausea, and changes in hair are frequently reported adverse effects. Breast tenderness, while it can occur with estrogen-containing therapies, is not consistently listed among the most common side effects in many summaries, and its frequency can vary with formulation, dose, and delivery method. Because of that variability, breast tenderness is the one most likely to be described as not a common side effect in this context.

Keep in mind that individual experiences can differ: some women may notice breast tenderness more with certain regimens, while others may have little or no tenderness. If tenderness develops, it’s reasonable to reassess the regimen and monitor for other potential causes, but overall the other listed symptoms tend to be more consistently encountered with hormone therapy.